NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
152.75
Dollar change
+0.34
Percentage change
0.22
%
IndexDJIA, S&P 500 P/E16.98 EPS (ttm)9.00 Insider Own0.14% Shs Outstand2.41B Perf Week0.95%
Market Cap367.53B Forward P/E13.75 EPS next Y11.11 Insider Trans-0.60% Shs Float2.40B Perf Month-0.54%
Enterprise Value381.00B PEG2.85 EPS next Q2.68 Inst Own73.49% Short Float0.68% Perf Quarter-6.69%
Income21.81B P/S4.11 EPS this Y6.39% Inst Trans0.81% Short Ratio1.77 Perf Half Y4.73%
Sales89.33B P/B4.70 EPS next Y4.63% ROA11.93% Short Interest16.33M Perf YTD5.62%
Book/sh32.47 P/C9.48 EPS next 5Y5.95% ROE29.45% 52W High169.99 -10.14% Perf Year4.04%
Cash/sh16.12 P/FCF18.04 EPS past 3/5Y-9.49% 0.55% ROIC18.73% 52W Low140.68 8.58% Perf 3Y-14.98%
Dividend Est.5.14 (3.37%) EV/EBITDA13.33 Sales past 3/5Y-1.79% 1.58% Gross Margin68.24% Volatility1.26% 1.32% Perf 5Y6.92%
Dividend TTM5.02 (3.29%) EV/Sales4.27 EPS Y/Y TTM29.21% Oper. Margin23.83% ATR (14)2.16 Perf 10Y52.61%
Dividend Ex-DateMay 27, 2025 Quick Ratio1.03 Sales Y/Y TTM-0.37% Profit Margin24.41% RSI (14)47.94 Recom2.20
Dividend Gr. 3/5Y5.43% 5.54% Current Ratio1.26 EPS Q/Q238.80% SMA20-0.60% Beta0.40 Target Price170.84
Payout84.80% Debt/Eq0.67 Sales Q/Q2.39% SMA50-0.74% Rel Volume0.97 Prev Close152.41
Employees138100 LT Debt/Eq0.49 EarningsJul 16 BMO SMA200-1.87% Avg Volume9.25M Price152.75
IPOSep 25, 1944 Option/ShortYes / Yes EPS/Sales Surpr.7.33% 1.55% Trades Volume9,039,552 Change0.22%
Date Action Analyst Rating Change Price Target Change
May-13-25Downgrade Leerink Partners Outperform → Market Perform $153
Dec-10-24Resumed BofA Securities Neutral $166
Nov-15-24Initiated Wolfe Research Outperform $190
Jul-23-24Downgrade Daiwa Securities Outperform → Neutral $160 → $150
May-30-24Resumed Goldman Neutral $160
Apr-18-24Upgrade HSBC Securities Hold → Buy $170
Dec-13-23Downgrade Wells Fargo Overweight → Equal Weight $170 → $163
Dec-01-23Upgrade UBS Neutral → Buy $167 → $180
Oct-05-23Initiated RBC Capital Mkts Outperform $178
Sep-06-23Initiated HSBC Securities Hold $175
Jun-30-25 02:33PM
01:27PM
10:00AM
07:00AM
06:45AM
05:38AM Loading…
Jun-27-25 05:38AM
04:12AM
01:16AM
Jun-26-25 09:03PM
09:40AM
08:45AM
06:12AM
06:00AM
Jun-25-25 03:08PM
04:29AM
03:47AM Loading…
03:47AM
Jun-24-25 01:06PM
12:20PM
10:25AM
08:00AM
05:18AM
03:39AM
Jun-23-25 02:31PM
09:51AM
09:40AM
09:22AM
09:15AM
08:00AM
07:32AM
05:05AM
02:01PM Loading…
Jun-21-25 02:01PM
12:12AM
Jun-20-25 03:54PM
06:39AM
Jun-19-25 12:40PM
09:00AM
07:08AM
Jun-18-25 06:43PM
10:00AM
06:20AM
05:05AM
05:02AM
Jun-17-25 05:16PM
12:11PM
09:37AM
06:20AM
06:20AM
Jun-16-25 05:45PM
09:00AM
07:43AM
Jun-15-25 10:00AM
05:33AM
03:15AM
Jun-13-25 09:30PM
08:56PM
12:45PM
11:30AM
11:10AM
11:00AM
08:19AM
04:25AM
Jun-12-25 11:57AM
11:00AM
05:40AM
Jun-11-25 04:45PM
10:57AM
10:20AM
09:50AM
09:36AM
09:34AM
08:05AM
07:00AM
06:20AM
06:20AM
05:35AM
05:00AM
Jun-10-25 04:51PM
04:25PM
03:52PM
10:10AM
09:02AM
06:20AM
Jun-09-25 11:33AM
05:53AM
Jun-07-25 03:00PM
05:59AM
Jun-06-25 04:16PM
04:08PM
09:33AM
07:39AM
Jun-05-25 09:00AM
Jun-04-25 12:17PM
05:00AM
04:48AM
Jun-03-25 05:45PM
04:57PM
04:41PM
11:02AM
10:45AM
10:45AM
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
REED JOHN CEVP, Innovative Medicine, R&DMay 01 '25Option Exercise0.0025,255040,797May 05 05:10 PM
Decker Robert JVP Corporate ControllerFeb 25 '25Option Exercise101.876,999712,98828,000Feb 26 06:42 PM
Decker Robert JVP Corporate ControllerFeb 25 '25Sale165.886,9991,160,99421,001Feb 26 06:42 PM
Decker Robert JOfficerFeb 25 '25Proposed Sale165.886,9991,161,010Feb 25 03:05 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 14 '25Option Exercise0.002,806017,904Feb 18 09:46 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 15 '25Option Exercise0.001,029015,501Feb 18 09:33 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 14 '25Option Exercise0.001,765015,111Feb 18 09:33 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 13 '25Option Exercise0.00499013,539Feb 18 09:33 PM
Schmid TimothyEVP, WW Chair, MedTechFeb 18 '25Sale156.1540362,92815,098Feb 18 09:33 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 15 '25Option Exercise0.00607091,037Feb 18 09:16 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 14 '25Option Exercise0.007,367096,674Feb 18 09:16 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 13 '25Option Exercise0.00651089,603Feb 18 09:16 PM
Wolk Joseph JExec VP, CFOFeb 15 '25Option Exercise0.001,97106,113Feb 18 09:13 PM
Wolk Joseph JExec VP, CFOFeb 14 '25Option Exercise0.0019,330020,661Feb 18 09:13 PM
Wolk Joseph JExec VP, CFOFeb 13 '25Option Exercise0.001,77901,779Feb 18 09:13 PM
REED JOHN CEVP, Innovative Medicine, R&DFeb 15 '25Option Exercise0.001,350015,927Feb 18 09:11 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 15 '25Option Exercise0.001,5940171,110Feb 18 09:08 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 14 '25Option Exercise0.0019,5180185,924Feb 18 09:08 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 13 '25Option Exercise0.001,3020167,221Feb 18 09:08 PM
Swanson James D.EVP, CIOFeb 15 '25Option Exercise0.00492016,762Feb 18 09:06 PM
Swanson James D.EVP, CIOFeb 14 '25Option Exercise0.005,079019,739Feb 18 09:06 PM
Swanson James D.EVP, CIOFeb 13 '25Option Exercise0.00447015,019Feb 18 09:06 PM
Mulholland KristenEVP, Chief HR OfficerFeb 15 '25Option Exercise0.00419013,095Feb 18 09:05 PM
Mulholland KristenEVP, Chief HR OfficerFeb 14 '25Option Exercise0.002,608014,576Feb 18 09:05 PM
Mulholland KristenEVP, Chief HR OfficerFeb 13 '25Option Exercise0.00411012,100Feb 18 09:05 PM
Forminard ElizabethExecutive VP, General CounselFeb 15 '25Option Exercise0.00961010,321Feb 18 09:03 PM
Forminard ElizabethExecutive VP, General CounselFeb 14 '25Option Exercise0.002,203011,366Feb 18 09:03 PM
Forminard ElizabethExecutive VP, General CounselFeb 13 '25Option Exercise0.0065108,991Feb 18 09:03 PM
Duato JoaquinCEO and Chairman of the BoardFeb 15 '25Option Exercise0.003,6820397,525Feb 18 09:02 PM
Duato JoaquinCEO and Chairman of the BoardFeb 14 '25Option Exercise0.0024,3350415,205Feb 18 09:02 PM
Duato JoaquinCEO and Chairman of the BoardFeb 13 '25Option Exercise0.003,4700392,498Feb 18 09:02 PM
Decker Robert JVP Corporate ControllerFeb 15 '25Option Exercise0.00339020,116Feb 18 09:01 PM
Decker Robert JVP Corporate ControllerFeb 14 '25Option Exercise0.002,201021,373Feb 18 09:01 PM
Decker Robert JVP Corporate ControllerFeb 13 '25Option Exercise0.00312019,285Feb 18 09:01 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 15 '25Option Exercise0.00492021,839Feb 18 08:58 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 14 '25Option Exercise0.004,740024,591Feb 18 08:58 PM
Broadhurst VanessaEVP, Global Corp AffairsFeb 13 '25Option Exercise0.00408020,242Feb 18 08:58 PM
Duato JoaquinCEO and Chairman of the BoardFeb 07 '25Option Exercise100.06126,36912,644,482489,671Feb 11 07:43 PM
Wengel Kathryn EEVP, Chief TO and Risk OfficerFeb 07 '25Option Exercise100.0632,7623,278,166115,028Feb 11 07:42 PM
Taubert Jennifer LEVP, WWC. Innovative MedicineFeb 07 '25Option Exercise100.0658,5045,853,910213,355Feb 11 07:41 PM
Wolk Joseph JExec VP, CFOFeb 07 '25Option Exercise100.0613,0151,302,28113,015Feb 11 07:40 PM
Wolk Joseph JExec VP, CFOFeb 07 '25Sale153.8913,0152,002,8780Feb 11 07:40 PM
Wolk Joseph JOfficerFeb 07 '25Proposed Sale153.8913,0152,002,924Feb 07 01:27 PM
WEINBERGER MARK ADirectorDec 12 '24Buy147.221,000147,2201,000Dec 12 05:27 PM
Hait WilliamFormer OfficerDec 04 '24Proposed Sale149.9025,7423,858,598Dec 04 01:25 PM
Decker Robert JVP Corporate ControllerAug 30 '24Option Exercise100.065,635563,83824,608Sep 03 04:48 PM
Decker Robert JVP Corporate ControllerAug 30 '24Sale165.065,635930,11318,973Sep 03 04:48 PM
Decker Robert JOfficerAug 30 '24Proposed Sale165.065,635930,113Aug 30 03:51 PM
Broadhurst VanessaEVP, Global Corp AffairsJul 08 '24Option Exercise0.009,809024,852Jul 09 05:48 PM